The top five key genes identified from the PPI analysis, namely TP53, JUN, AKT1, STAT3, and MAPK3, are crucial targets not only in NSCLC but also in various other cancers [63–67]. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.